BILAYER THERAPEUTICS
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
BILAYER THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.bilayer-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
734-358-9015
Email Addresses:
[email protected]
Total Funding:
2 M USD
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Thrombolytic Science International
Thrombolytic Science International develops a clot-dissolving therapy for stroke and other thrombotic diseases.
Tiaki Therapeutics
Tiaki Therapeutics is committed to developing microglia-targeted therapeutics for the treatment of dementias.
Via Nova Therapeutics
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Investors List
Kendall Capital Partners
Kendall Capital Partners investment in Venture Round - Bilayer Therapeutics
Official Site Inspections
http://www.bilayer-therapeutics.com
- Host name: 241.114.215.35.bc.googleusercontent.com
- IP address: 35.215.114.241
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Bilayer Therapeutics"
Bilayer Therapeutics - Crunchbase Company Profile
Organization. Bilayer Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Bilayer Therapeutics is a biotech company that develops a first-in-class …See details»
Bilayer Therapeutics Company Profile 2024: Valuation, …
Bilayer Therapeutics was founded in 2020. Where is Bilayer Therapeutics headquartered? Bilayer Therapeutics is headquartered in Cambridge, MA. What is the size of Bilayer Therapeutics? Bilayer Therapeutics has 3 total …See details»
Bilayer Therapeutics, Inc. | BioPharm America - Informa Connect
Bilayer Therapeutics, Inc. Profile. Company/Organization Description. Bilayer Therapeutic, Inc. was formed to develop BL-010, a bile acid-based, first-in-class therapeutic for constipation and …See details»
Bilayer Therapeutics - LinkedIn
Bilayer Therapeutics is a development-stage company founded by a team of world-renowned drug development and delivery experts and gastroenterologists. Its technology stimulates the body’s innate ...See details»
BILAYER THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BILAYER THERAPEUTICS, INC. of Cambridge, MA. Get the latest business insights from Dun & …See details»
Thomas A. Collet, PhD - Bilayer Therapeutics
Thomas Collet is a serial life sciences entrepreneur with deep drug development expertise. He serves as President, CEO and Director of Bilayer Therapeutics. Dr. Collet has founded and led …See details»
Bilayer Therapeutics - Contacts, Employees, Board Members
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. Search Crunchbase. Start Free Trial . Chrome …See details»
Bilayer Therapeutics - Funding, Financials, Valuation & Investors
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. ... Solutions. Products. Resources. Pricing. …See details»
Giovanni Traverso, MD, PhD - Bilayer Therapeutics
Giovanni Traverso is an Assistant Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT) and also a gastroenterologist in the Division of Gastroenterology, Brigham and Women’s …See details»
Bilayer Therapeutics | MIT Technology Licensing Office
Technology Licensing Office Massachusetts Institute of Technology 255 Main Street, Room NE18-501 Cambridge, MA 02142-1601. 617-253-6966 | [email protected]See details»
Bilayer Therapeutics, Inc. - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Bilayer …See details»
Bilayer Therapeutics - Updates, News, Events, Signals & Triggers
Apr 28, 2021 Organization. Bilayer Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. ... Edit Recent News & Activity Section. Funding Round • Apr …See details»
BL-010 (Bilayer Therapeutics) - Drug Targets, Indications ... - Patsnap
Nov 21, 2024 BL-010 (Bilayer Therapeutics), Initially developed by Bilayer Therapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System …See details»
Bilayer Therapeutics - workinbiotech.com
Ilayer Therapeutics, a development-stage biotech company, provides a novel approach to developing treatments for gastrointestinal disease and metabolic disorder. They were founded …See details»
Privacy Policy - Bilayer Therapeutics
Bilayer Therapeutics, Inc. is the operator of this website (“Bilayer,” “we” and “us”) and we care about your privacy. ... Also, as noted above, your registration may be controlled by your …See details»
Thomas Collet - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... BILAYER THERAPEUTICS, …See details»
Bilayer Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Bilayer Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. ...See details»
BL-040 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 BL-040, Initially developed by Bilayer Therapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Digestive System Disorders, Active ...See details»
Bilayered delivery system offers new solution for treating IBS-C …
Dec 9, 2020 Within the next 18 months, clinical trials will begin for the bilayered delivery of CDC to IBS-C patients, with pill production regulated by the team's newly founded Bilayer …See details»